ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp. ...Middle East

ZyVersa is a clinical stage biopharmaceutical company developing first-in-class product candidates to address significant unmet medical needs of patients with renal and inflammatory diseases Lead renal product candidate, phase 2a-ready VAR 200, mediates removal of excess intracellular...

Hence then, the article about zyversa therapeutics to become a publicly traded biopharma company via merger with larkspur health acquisition corp was published today ( Thursday 21/07/2022 - 12:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ZyVersa Therapeutics to Become a Publicly Traded Biopharma Company via Merger with Larkspur Health Acquisition Corp. )

Also on site :

• Paul Rudd Reveals the Unexpected Reason Why He Almost Lost His ‘Clueless’ Role
• Thousands of mutilated kids will sue ‘Mengele’ gender surgeons – Musk
• Numbrix 9 - February 1